In DepthPUBLIC HEALTH

Dengue researcher faces charges in vaccine fiasco

See allHide authors and affiliations

Science  26 Apr 2019:
Vol. 364, Issue 6438, pp. 320
DOI: 10.1126/science.364.6438.320

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

Rose Capeding, former head of the dengue department of the Research Institute for Tropical Medicine in Manila, has been indicted in a series of criminal cases over the failed introduction in the Philippines of Dengvaxia, a vaccine against dengue that was yanked from the market in 2017 because of safety issues. In February, a panel of prosecutors concluded that there is probable cause to indict Capeding and 19 others for "reckless imprudence resulting [in] homicide," because of their role in the vaccine's approval and rollout. If convicted of accusations leveled at her by the national Department of Justice, Capeding could face up to 48 years in prison. Many scientists have come to her defense.

  • * Fatima Arkin is a science journalist in Manila.